TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers.

Oliver Ackaert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.